Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,617-2,628 of 4,306
Drug study icon
CompletedNCT00254241

Safety and Efficacy of Seroquel in First Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
United Kingdom
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT00063297

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Other study type icon
CompletedNCT00690365

Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT01295372

Safety and Efficacy of Zicronapine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Brno
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, Czechia, Estonia, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Drug study icon
TerminatedNCT00257192

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, Colombia, Costa Rica, ...
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02773576

Safety and Tolerability of Risperidone Implants

This summary needs review. Please check the official study record and contact the research team for details.

In Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Braeburn Pharmaceuticals
Condition
Schizophrenia
Drug study icon
TerminatedNCT00265382

Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, Colombia, Costa Rica, ...
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00044005

Safety and Tolerability Study of Drug to Treat Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.